Dianthus Therapeutics, Inc. (DNTH)
86.48
-3.15
(-3.51%)
USD |
NASDAQ |
May 22, 16:00
86.41
-0.07
(-0.08%)
After-Hours: 20:00
Dianthus Therapeutics EPS Diluted (Quarterly) : -0.8501 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Kodiak Sciences, Inc. | -0.9402 |
| Praxis Precision Medicines, Inc. | -3.205 |
| Erasca, Inc. | -0.6028 |
| Tango Therapeutics, Inc. | -0.317 |
| Tyra Biosciences, Inc. | -0.6366 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -40.83M |
| Revenue (Quarterly) | 0.463M |
| Total Expenses (Quarterly) | 41.30M |
| Enterprise Value | 3.618B |
| Gross Profit Margin (Quarterly) | 83.59% |
| Profit Margin (Quarterly) | -8.82K% |
| Earnings Yield | -4.79% |
| Normalized Earnings Yield | -4.786 |